Tolerability and antitumor activity of cemiplimab, a human monoclonal anti–PD-1, as monotherapy in patients with pretreated non-small cell lung cancer (NSCLC): Data from the Phase... by Moreno, Victor, Garrido, Pilar, Papadopoulos, Kyriakos P., De Miguel Luken, Maria Jose, Gil-Martin, Marta, Aljumaily, Raid, Rosen, Lee S., Rietschel, Petra, Mohan, Kosalai K., Yoo, Suk-Young, Stankevich, Elizabeth, Lowy, Israel, Fury, Matthew G.

Get full text

428 Interim analysis of Phase 2 results for cemiplimab in patients with metastatic basal cell carcinoma (mBCC) who progressed on or are intolerant to hedgehog inhibitors (HHIs) by Lewis, Karl, Peris, Ketty, Sekulic, Aleksandar, Stratigos, Alexander, Dunn, Lara, Eroglu, Zeynep, Chang, Anne Lynn, Migden, Michael, Li, Siyu, Mohan, Kosalai, Coates, Ebony, Okoye, Emmanuel, Baurain, Jean-François, Bechter, Oliver, Hauschild, Axel, Butler, Marcus, Hernandez-Aya, Leonel, Licitra, Lisa, Neves, Rogerio, Ruiz, Emily, Seebach, Frank, Weinreich, David, Yancopoulos, George, Lowy, Israel, Bowler, Timothy, Fury, Matthew

Get full text

Cemiplimab in locally advanced basal cell carcinoma after hedgehog inhibitor therapy: an open-label, multi-centre, single-arm, phase 2 trial by Stratigos, Alexander J, Sekulic, Aleksandar, Peris, Ketty, Bechter, Oliver, Prey, Sorilla, Kaatz, Martin, Lewis, Karl D, Basset-Seguin, Nicole, Chang, Anne Lynn S, Dalle, Stèphane, Orland, Almudena Fernandez, Licitra, Lisa, Robert, Caroline, Ulrich, Claas, Hauschild, Axel, Migden, Michael R, Dummer, Reinhard, Li, Siyu, Yoo, Suk-Young, Mohan, Kosalai, Coates, Ebony, Jankovic, Vladimir, Fiaschi, Nathalie, Okoye, Emmanuel, Bassukas, Ioannis D, Loquai, Carmen, De Giorgi, Vincenzo, Eroglu, Zeynep, Gutzmer, Ralf, Ulrich, Jens, Puig, Susana, Seebach, Frank, Thurston, Gavin, Weinreich, David M, Yancopoulos, George D, Lowy, Israel, Bowler, Timothy, Fury, Matthew G

Get full text

52-Week Open-Label Extension Data from a Phase 2 Study Evaluating the Safety and Efficacy of Pozelimab and Cemdisiran Combination Therapy in Patients with Paroxysmal Nocturnal Hemo... by Kelly, Richard J., Houghton, Nicola, Munir, Talha, Muus, Petra, Youngs, Nora, Aurand, Lisa, Mohan, Kosalai, Senk, Brian, Pavani, Rodrigo, Perlee, Lorah, Souttou, Amal, Griffin, Morag

Get full text

Phase I Trial of Cemiplimab, Radiotherapy, Cyclophosphamide, and Granulocyte Macrophage Colony‐Stimulating Factor in Patients with Recurrent or Metastatic Head and Neck Squamous Ce... by Babiker, Hani, Brana, Irene, Mahadevan, Daruka, Owonikoko, Taofeek, Calvo, Emiliano, Rischin, Danny, Moreno, Victor, Papadopoulos, Kyriakos P., Crittenden, Marka, Formenti, Silvia, Giralt, Jordi, Garrido, Pilar, Soria, Ainara, Hervás‐Morón, Asunción, Mohan, Kosalai Kal, Fury, Matthew, Lowy, Israel, Mathias, Melissa, Feng, Minjie, Li, Jingjin, Stankevich, Elizabeth

Get full text

Primary analysis of Phase 2 results for cemiplimab in patients with metastatic basal cell carcinoma who progressed on or were intolerant to hedgehog inhibitors by Lewis, Karl D, Peris, Ketty, Sekulic, Aleksandar, Stratigos, Alexander J, Dunn, Lara, Eroglu, Zeynep, Chang, Anne Lynn S, Migden, Michael R, Yoo, Suk-Young, Mohan, Kosalai, Coates, Ebony, Okoye, Emmanuel, Baurain, Jean-François, Bechter, Oliver, Hauscild, Axel, Butler, Marcus O, Hernandez-Aya, Leonel, Licitra, Lisa, Neves, Rogerio I, Ruiz, Emily S, Seebach, Frank, Lowy, Israel, Goncalves, Priscila, Fury, Matthew G

Get full text

Abstract CT165: Primary analysis of phase 2 results for cemiplimab in patients with metastatic basal cell carcinoma who progressed on or were intolerant to hedgehog inhibitors by Lewis, Karl, Peris, Ketty, Sekulic, Aleksander, Stratigos, Alexander J., Dunn, Lara, Eroglu, Zeynep, Chang, Anne Lynn S., Migden, Michael R., Yoo, Suk-Young, Mohan, Kosalai, Coates, Ebony, Okoye, Emmanuel, Bowler, Timothy, Baurain, Jean-François, Bechter, Oliver, Hauschild, Axel, Butler, Marcus O., Hernandez-Aya, Leonel, Licitra, Lisa, Neves, Rogerio I., Ruiz, Emily S., Seebach, Frank, Weinreich, David M., Yancopoulos, George D., Lowy, Israel, Goncalves, Priscila, Fury, Matthew G.

Get full text

Phase I Trial of Cemiplimab, Radiotherapy, Cyclophosphamide, and GM-CSF in Patients with Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma by Babiker, Hani M, Brana, Irene, Mahadevan, Daruka, Owonikoko, Taofeek, Calvo, Emiliano, Rischin, Danny, Moreno, Victor, Papadopoulos, Kyriakos P, Crittenden, Marka, Formenti, Silvia, Giralt, Jordi, Garrido, Pilar, Soria, Ainara, Hervás-Morón, Asunción, Mohan, Kosalai Kal, Fury, Matthew, Lowy, Israel, Mathias, Melissa, Feng, Minjie, Li, Jingjin, Stankevich, Elizabeth

Get full text